Nutraceutical”Chrome-DS”, combining the beneficial properties of chromium and aspartic acid, is recommended for people who are deficient in chromium and suffer from it. It is an additional source of chromium. It is not a medicine.
Ingredients: 1 pill contains 2 mg of chromium (III) asparaginate (0.2 ± 0.02 mg of chromium, which corresponds to 400% of the adequate level of adult consumption per day and does not exceed the upper acceptable level of consumption)glucose (carrying), calcium stearate (emulgent), gelatin (gelling material).
Pharmacological action: Chromium is a vital trace element that is involved in the regulation of carbohydrate and fat metabolism, the activity of the heart muscle, and blood vessels. Chromium deficiency significantly increases the risk of atherosclerosis, diabetes mellitus, leads to disruption of protein metabolism, the development of coronary heart disease, promotes weight gain, the appearance of various forms of anxiety, insomnia, headaches, acne. Chromium helps to overcome stress, improves digestion, promotes weight loss and muscle growth.
The formula of the nutraceutical includes aspartic acid, which is related to replaceable amino acids, which is the most promising carrying agent of trace elements among amino acids due to its unique ability not only to penetrate into those systems of the body that lack bio-elements, but also to contribute to their accumulation in target organs. In addition, it has a tonic effect on the central nervous system, improves energy metabolism,hematolysis.
ТУ 9197-008-14652947-14
СГР RU.77.99.88.003.E.004571.03.15 от 10.03.2015 <
Indications:
Indications for use in laboratory-confirmed chromium deficiency (A. Skalny, I. Rudakov Bioelements in medicine. – M .: ‘Onyx 21st Century’: Mir, 2004. – 272 p.):
– fatigue, anxiety, insomnia, headaches;
– increasing cholesterol, triglycerides in the blood, the risk of atherosclerosis;
– changes in body weight (emaciation, obesity);
– decrease in glucose tolerance, especially in middle-aged and elderly people;
– changes in blood glucose (hyperglycemia, hypoglycemia), the risk of type 2 diabetes
– risk of coronary heart disease;
– neuralgia and reduced sensitivity of the limbs; loss of muscle coordination, trembling inlimbs. <